ABR volunteer and radiation oncologist Kenneth Rosenzweig, MD, has been named to the organization’s Board of Trustees (BOT). Dr. Rosenzweig will start at the end of the fall board meeting in late September.
Dr. Rosenzweig is chair of the department of radiation oncology at Mount Sinai Health System and a professor in the department of radiation oncology at the Icahn School of Medicine at Mount Sinai in New York.
Dr. Rosenzweig earned his board certification in 1997 and has been an ABR volunteer since 2002, serving in multiple roles, including question writer and oral examiner. He most recently served as chair of the lung/sarcoma section of the Qualifying Exam. He received the ABR Lifetime Service Award in 2015.
In addition to his ABR duties, Dr. Rosenzweig has also served as:
- President of the American Radium Society, the nation’s oldest society dedicated to the study of cancer.
- Chair of the Scientific Committee of ASTRO’s annual meeting.
- Vice-Chair of the Radiation Oncology Residency Review Committee of the American College of Graduate Medical Education.
- A member of numerous other panels and committees.
Dr. Rosenzweig earned his medical degree from the Yale University School of Medicine and completed his residency at the Joint Center for Radiation Therapy at Harvard Medical School.
The BOT advances the quality, relevance, and effectiveness of the ABR’s exams for Initial and Continuing Certification across radiology, radiation oncology, and medical physics. The BOT makes recommendations to the Board of Governors regarding assessment structure including, but not limited to, exam format, content, assembly, delivery, scoring, and feedback.
